Source: Appen
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Appen (ASX:APX) appoints Ryan Kolln as its new CEO and Managing Director
  • Mr Kolln brings an extensive understanding of Appen’s business and the AI industry to the role
  • His journey within Appen saw him take on the role of COO in 2023, where he oversaw global operations and strategy
  • Mr Kolln will be based in North America
  • APX shares are down 1.79 per cent, trading at 27.5 cents at 1:51 pm AEDT

Appen (ASX:APX) has announced the immediate appointment of Ryan Kolln as its new CEO and Managing Director, succeeding Armughan Ahmad, who has stepped down.

Bringing 20 years of experience in global technology and telecommunications, Mr Kolln is well-versed in Appen’s business and the AI industry.

Appen Chair Richard Freudenstein expressed the Board’s enthusiasm for Mr Kolln’s appointment.

“He has a deep understanding of Appen’s history, a strong technical understanding of the AI market, and a proven strategy background,” he said.

“This unique combination is ideal to guide Appen through its next phase and navigate the evolving generative AI market.”

Mr Kolln joined Appen AI in 2018 as VP of Corporate Development, playing a pivotal role in strategic acquisitions and contributed to the establishment of the China and Federal divisions.

His journey within Appen saw him take on the role of Chief Operating Officer in 2023, where he oversaw global operations and strategy.

Mr Kolln will continue to be based in North America.

APX shares were down 1.79 per cent, trading at 27.5 cents at 1:51 pm AEDT.

APX by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…